Deutsche Bank Ag\ Tricida, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.14 - $12.49 $350 - $31,274	2,504 Added 0.57%	443,531 $66,000
Q3 2022 Nov 14, 2022	SELL	$8.51 - $13.6 $38,303 - $61,213	-4,501 Reduced 1.01%	441,027 $4.62 Million
Q2 2022 Aug 11, 2022	BUY	$7.31 - $11.85 $131,755 - $213,584	18,024 Added 4.22%	445,528 $4.31 Million
Q3 2021 Nov 04, 2021	SELL	$3.56 - $4.64 $226,202 - $294,825	-63,540 Reduced 12.94%	427,504 $1.98 Million
Q2 2021 Aug 11, 2021	SELL	$3.95 - $5.41 $33,547 - $45,947	-8,493 Reduced 1.7%	491,044 $2.12 Million
Q1 2021 May 13, 2021	SELL	$4.52 - $7.8 $111,924 - $193,143	-24,762 Reduced 4.72%	499,537 $2.64 Million
Q4 2020 Feb 16, 2021	BUY	$4.37 - $9.46 $2.16 Million - $4.68 Million	494,307 Added 1648.13%	524,299 $3.7 Million
Q3 2020 Nov 12, 2020	BUY	$8.56 - $26.93 $114,549 - $360,377	13,382 Added 80.57%	29,992 $271,000
Q2 2020 Aug 13, 2020	BUY	$21.21 - $31.55 $181,960 - $270,667	8,579 Added 106.82%	16,610 $457,000
Q1 2020 May 14, 2020	SELL	$18.43 - $38.04 $355,588 - $733,943	-19,294 Reduced 70.61%	8,031 $177,000
Q4 2019 Feb 14, 2020	BUY	$29.6 - $43.71 $624,204 - $921,756	21,088 Added 338.11%	27,325 $1.03 Million
Q3 2019 Nov 14, 2019	SELL	$29.87 - $42.22 $279,732 - $395,390	-9,365 Reduced 60.02%	6,237 $191,000
Q2 2019 Aug 14, 2019	SELL	$31.16 - $39.46 $71,138 - $90,087	-2,283 Reduced 12.76%	15,602 $614,000
Q1 2019 May 15, 2019	BUY	$19.96 - $38.62 $167,304 - $323,712	8,382 Added 88.2%	17,885 $687,000
Q4 2018 Feb 14, 2019	SELL	$23.57 - $32.33 $399,487 - $547,961	-16,949 Reduced 64.07%	9,503 $223,000
Q3 2018 Dec 21, 2021	BUY	$22.5 - $39.35 $69,255 - $121,119	3,078 Added 13.17%	26,452 $808,000
Q3 2018 Nov 14, 2018	BUY	$22.5 - $39.35 $525,915 - $919,766	23,374 New	23,374 $713,000

Others Institutions Holding TCDA

# of Institutions

Shares Held

30K

Call Options Held

124K

Put Options Held

46.5K

View Full List

About Tricida, Inc.

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

More about TCDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account